CVS Health (CVS) to Release Quarterly Earnings on Wednesday

CVS Health (NYSE:CVS) is expected to announce its Q1 2026 results before the market opens on Wednesday, May 6th. Analysts expect the company to announce earnings of $2.21 per share and revenue of $94.9685 billion for the quarter. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Investors are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 8:00 AM ET.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The company had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period last year, the firm earned $1.19 EPS. On average, analysts expect CVS Health to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

CVS Health Stock Performance

NYSE:CVS opened at $82.06 on Tuesday. CVS Health has a fifty-two week low of $58.35 and a fifty-two week high of $85.15. The firm’s 50 day moving average is $76.32 and its two-hundred day moving average is $77.96. The company has a market cap of $105.17 billion, a P/E ratio of 59.47, a P/E/G ratio of 0.86 and a beta of 0.60. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. CVS Health’s dividend payout ratio is presently 192.75%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on CVS shares. Piper Sandler dropped their price objective on shares of CVS Health from $101.00 to $99.00 and set an “overweight” rating for the company in a research report on Tuesday, March 31st. Leerink Partners restated an “outperform” rating and issued a $98.00 target price on shares of CVS Health in a research note on Thursday, March 5th. The Goldman Sachs Group upped their target price on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Argus decreased their target price on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. Finally, Wolfe Research decreased their target price on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating for the company in a research note on Monday, March 2nd. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.05.

Institutional Investors Weigh In On CVS Health

A number of institutional investors have recently made changes to their positions in CVS. Mcguire Capital Advisors Inc. acquired a new position in shares of CVS Health during the fourth quarter valued at $28,000. Compound Planning Inc. lifted its stake in CVS Health by 49.3% in the 4th quarter. Compound Planning Inc. now owns 33,934 shares of the pharmacy operator’s stock worth $2,693,000 after acquiring an additional 11,209 shares in the last quarter. Corient Private Wealth LLC increased its position in CVS Health by 45.4% in the 4th quarter. Corient Private Wealth LLC now owns 544,487 shares of the pharmacy operator’s stock worth $43,210,000 after purchasing an additional 170,023 shares during the last quarter. Strive Financial Group LLC acquired a new stake in CVS Health in the fourth quarter valued at approximately $197,000. Finally, Mercer Global Advisors Inc. ADV lifted its stake in CVS Health by 12.2% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 141,136 shares of the pharmacy operator’s stock valued at $11,201,000 after acquiring an additional 15,396 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.